JUNS
JUPITER NEUROSCIENCES, INC.
NASDAQ · Healthcare · Biotechnology · US
$2.82
−2.93%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$3.75
- Revenue estimate
- $602.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$5.06
- EPS estimate
- -$3.75
- Revenue actual
- $24.2K
- Revenue estimate
- $400.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -10.6%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$3.75 | -$5.06 | Miss -34.93% | $24.2K |
| May 14, 2026 | -$0.05 | -$0.06 | Miss -20.00% | $18.7K |
| Nov 14, 2025 | -$0.08 | -$0.07 | Beat 12.50% | — |
| Aug 18, 2025 | -$0.07 | -$0.07 | In line | — |
| May 15, 2025 | -$0.03 | -$0.05 | Miss -66.67% | — |
| Mar 28, 2025 | -$0.02 | -$0.05 | Miss -150.00% | — |
| Dec 23, 2024 | — | -$0.02 | — | — |
| Jun 30, 2024 | — | $0.01 | — | — |
| Mar 31, 2024 | — | -$0.02 | — | — |
| Dec 31, 2023 | — | -$0.01 | — | — |
| Sep 30, 2023 | — | -$0.07 | — | — |
| Jun 30, 2023 | — | -$0.03 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026